{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T13:15:18Z","timestamp":1715260518709},"reference-count":63,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>Objective: To investigate the influence of a regular oral use of acetylsalicylic acid in the prevalence of actinic keratosis. Methods: A case-control study with dermatologic outpatients above 50 years of age assessed between 2009 and 2011. Cases were defined as those who had been under regular use of oral acetylsalicylic acid for more than six consecutive months. The assessment focused on: age, sex, skin-type, tobacco smoking, use of medication, occurrence of individual or family skin cancer, and sunscreen and sun exposure habits. Actinic keratoses were counted in the medial region of the face and upper limbs. Counts were adjusted by co-variables based on a generalized linear model. Results: A total of 74 cases and 216 controls were assessed. The median time of acetylsalicylic acid use was 36 months. Cases differed from controls as to the highest age, highest prevalence of use of angiotensin-converting enzyme inhibitors and fewer keratosis on the face and on the upper limbs (p&lt;0.05). The multivariate model showed that the use of acetylsalicylic acid was associated to lower counts of face actinic keratosis and upper-limb erythematous actinic keratosis (p&lt;0.05), regardless of other risk factors. Conclusion: The regular use of oral acetylsalicylic acid for more than six months was associated to a lower prevalence of actinic keratosis, especially facial and erythematous ones.<\/jats:p>","DOI":"10.1590\/1806-9282.60.02.010","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T15:05:21Z","timestamp":1402671921000},"page":"131-138","source":"Crossref","is-referenced-by-count":4,"title":["Oral acetylsalicylic acid and prevalence of actinic keratosis"],"prefix":"10.1590","volume":"60","author":[{"given":"Juliano","family":"Schmitt","sequence":"first","affiliation":[{"name":"Sao Paulo State University, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio","family":"Miot","sequence":"additional","affiliation":[{"name":"Sao Paulo State University, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S0365-05962012000300012","article-title":"Actinic keratosis: a clinical and epidemiological revision","volume":"87","author":"Schmitt JV","year":"2012","journal-title":"An Bras Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Salasche SJ","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.0366-077X.2003.05621.x","article-title":"Actinic keratosis: epidemiology and progression to squamous cell carcinoma","volume":"149","author":"Lebwohl M","year":"2003","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","article-title":"Actinic keratosis","volume":"46","author":"Rossi R","year":"2007","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione VD","year":"2009","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1994.tb08544.x","article-title":"Epidemiology of solar keratoses","volume":"131","author":"Frost CA","year":"1994","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1590\/S0365-05962006000600006","article-title":"Perfil nosol\u00f3gico das consultas dermatol\u00f3gicas no Brasil","volume":"81","year":"2006","journal-title":"An Bras Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2011.289","article-title":"Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?","volume":"105","author":"Langley RE","year":"2011","journal-title":"Br J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ajg.2011.38","article-title":"Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort","volume":"106","author":"Ruder EH","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaad.2010.05.042","article-title":"Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study","volume":"65","author":"Torti DC","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/jid.2011.58","article-title":"Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study","volume":"131","author":"Curiel-Lewandrowski C","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.jid.5700191","article-title":"Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis","volume":"126","author":"Tjiu JW","year":"2006","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.07856.x","article-title":"The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"156","author":"Fecker LF","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00128071-200405030-00001","article-title":"Quantifying actinic keratosis: assessing the evidence","volume":"5","author":"Epstein E","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2005.11.007","article-title":"Testing experimental data for univariate normality","volume":"366","author":"Henderson AR","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00223890802634175","article-title":"The analysis of count data: a gentle introduction to poisson regression and its alternatives","volume":"91","author":"Coxe S","year":"2009","journal-title":"J Pers Assess"},{"key":"ref17","series-title":"Biostatistics. The bare essentials","author":"Norman GR","year":"2008","edition":"3rd ed"},{"key":"ref18","series-title":"Multivariable analysis.A practical guide for clinicians","author":"Katz MH","year":"2006","edition":"2nd ed"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3945\/ajcn.2008.27053","article-title":"Food intake, dietary patterns, and actinic keratoses of the skin: a longitudinal skin: a longitudinal skin: a longitudinal study","volume":"89","author":"Hughes MC","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2796.2010.02274.x","article-title":"The use and reporting of multiple imputation in medical research - a review","volume":"268","author":"Mackinnon A","year":"2010","journal-title":"J Intern Med"},{"key":"ref21","series-title":"SPSS 17.0 for Windows","year":"2008","edition":"17 ed"},{"key":"ref22","first-page":"85","article-title":"Unconditioned logistic regression and sample size: a bibliographic review","volume":"76","author":"Ortega Calvo M","year":"2002","journal-title":"Rev Esp Salud Publica"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/sim.2771","article-title":"Sample size determination for logistic regression revisited","volume":"26","author":"Demidenko E","year":"2007","journal-title":"Stat Med"},{"key":"ref24","first-page":"547","article-title":"Effects of selective and non-selective cyclooxygenase-2 inhibitor on the growth of colon cancer cells","volume":"37","author":"Wang CH","year":"2006","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/excr.1996.0113","article-title":"Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation","volume":"224","author":"Leong J","year":"1996","journal-title":"Exp Cell Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/19.5.723","article-title":"COX2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer","volume":"19","author":"Buckman SY","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1562\/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2","article-title":"Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches","volume":"76","author":"An KP","year":"2002","journal-title":"Photochem Photobiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11596-007-0227-6","article-title":"Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors","volume":"27","author":"Wu Y","year":"2007","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.2004.06214.x","article-title":"Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases","volume":"151","author":"Nijsten T","year":"2004","journal-title":"Br J Dermatol"},{"key":"ref30","first-page":"3395","article-title":"Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis","volume":"62","author":"Tiano HF","year":"2002","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.192323799","article-title":"Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis","volume":"99","author":"Muller-Decker K","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2133.2002.04720.x","article-title":"Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans","volume":"146","author":"Berhane T","year":"2002","journal-title":"Br J Dermatol"},{"key":"ref33","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng H","year":"1998","journal-title":"Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0014-5793(02)02689-3","article-title":"Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3","volume":"518","author":"Yano T","year":"2002","journal-title":"FEBS Lett"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-4615-0193-0_62","article-title":"Growth stimulation and epidermal growth factor receptor induction in cyclooxygenase-overexpressing human colon carcinoma cells","volume":"507","author":"Yoshimoto T","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.humpath.2004.08.010","article-title":"COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals","volume":"35","author":"O'Grady A","year":"2004","journal-title":"Hum Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis","volume":"25","author":"Fischer SM","year":"1999","journal-title":"Mol Carcinog"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archderm.138.6.751","article-title":"Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model","volume":"138","author":"Orengo IF","year":"2002","journal-title":"Arch Dermatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1751-1097.2008.00303.x","article-title":"Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice","volume":"84","author":"Tang X","year":"2008","journal-title":"Photochem Photobiol"},{"key":"ref40","first-page":"547","article-title":"Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell lines","volume":"19","author":"Bundscherer A","year":"2008","journal-title":"Oncol Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2005.05.049","article-title":"Nonsteroidal antiinflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin","volume":"53","author":"Butler GJ","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/pds.1718","article-title":"Effect of non-steroidal antiinflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial","volume":"18","author":"Clouser MC","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/archdermatol.2009.374","article-title":"Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma","volume":"146","author":"Asgari MM","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets CA","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1940-6207.CAPR-09-0200","article-title":"Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+\/- humans and mice","volume":"3","author":"Tang JY","year":"2010","journal-title":"Cancer Prev Res"},{"key":"ref46","first-page":"447","article-title":"Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer","volume":"10","author":"Krishnan K","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/carcin\/bgl220","article-title":"Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer","volume":"28","author":"Stark LA","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref48","first-page":"383","article-title":"A novel mechanism for aspirin-mediated growth inhibition of human colon cancer cells","volume":"9","author":"Goel A","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjc.6602455","article-title":"Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency","volume":"92","author":"Din FV","year":"2005","journal-title":"Br J Cancer"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/jnci\/djn262","article-title":"Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial","volume":"100","author":"Christian JB","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5414\/CNP73439","article-title":"Keratinocyte cancer prevention with ACE inhibitors, angiotensin receptor blockers or their combination in renal transplant recipients","volume":"73","author":"Moscarelli L","year":"2010","journal-title":"Clin Nephrol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.amjoto.2011.02.001","article-title":"Human papillomavirus, smoking, and head and neck cancer","volume":"33","author":"Sinha P","year":"2012","journal-title":"Am J Otol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/00016340902846072","article-title":"Smoking worsens the prognosis of mild abnormalities in cervical cytology","volume":"88","author":"Guarisi R","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2001.19.1.231","article-title":"Relation between smoking and skin cancer","volume":"19","author":"De Hertog SA","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/1756-0500-4-556","article-title":"The relationship between basal and squamous cell skin cancer and smoking related cancers","volume":"4","author":"Sitas F","year":"2011","journal-title":"BMC Res Notes"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10552-011-9872-y","article-title":"Case-control study of smoking and non-melanoma skin cancer","volume":"23","author":"Rollison DE","year":"2012","journal-title":"Cancer Causes Control"},{"key":"ref57","first-page":"2","article-title":"Association between solitary keratoacanthoma and cigarette smoking: a case-control study","volume":"12","author":"Miot HA","year":"2006","journal-title":"Dermatol Online J"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00125480-199809000-00001","article-title":"Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma","volume":"5","author":"Beham A","year":"1998","journal-title":"Adv Anat Pathol"},{"key":"ref59","first-page":"335","article-title":"Actinic keratosis: how to differentiate the good from the bad ones?","volume":"16","author":"Quaedvlieg PJ","year":"2006","journal-title":"Eur J Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson SC","year":"1993","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1684\/ejd.2009.0706","article-title":"Predisposing factors of actinic keratosis in a North-West German population","volume":"19","author":"Hensen P","year":"2009","journal-title":"Eur J Dermatol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2133.2009.09453.x","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161","author":"Ulrich C","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.jid.5700110","article-title":"Reliable methods to evaluate the burden of actinic keratoses","volume":"126","author":"Atkins D","year":"2006","journal-title":"J Invest Dermatol"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v60n2\/0104-4230-ramb-60-02-0131.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:10:44Z","timestamp":1597968644000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302014000200131&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"alternative-id":["S0104-42302014000200131"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.60.02.010","relation":{},"ISSN":["0104-4230"],"issn-type":[{"value":"0104-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}